|
⚲
|
| Keyboard |
| Kamarck Michael E
✚
|
|
|---|---|
| CIK # | 0001450730 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001450730] | |
| 4 | [0001450730] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Kamarck Michael E | |
| Vaxcyte Inc | |
| Passage Bio Inc | |
| Trillium Therapeutics Inc | |
| Vir Biotechnology Inc | |
| Unilife Corp | |
| OMNI Bio Pharmaceutical Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Vaxcyte Inc PCVX
Common Stock
|
2023-06-13 | Grant | 2,500 | $0.00 | |
|
Vaxcyte Inc PCVX
Stock Option (right to buy) · derivative
|
2023-06-13 | Grant | 15,000 | $0.00 | |
|
Passage Bio Inc PASG
Director Stock Option (Right to Buy) · derivative
|
2023-05-25 | Grant | 21,567 | $0.00 | |
|
Passage Bio Inc PASG
Stock Option (right to buy) · derivative
|
2022-07-05 | Grant | 48,000 | $0.00 | |
|
Vaxcyte Inc PCVX
Stock Option (right to buy) · derivative
|
2022-06-01 | Grant | 18,750 | $0.00 | |
|
Vaxcyte Inc PCVX
Common Stock
|
2022-06-01 | Grant | 3,125 | $0.00 | |
|
Trillium Therapeutics Inc TRIL
Stock Option (Right to Buy) · derivative
|
2021-11-17 | Disposed to issuer | 67,000 | $0.00 | |
|
Vaxcyte Inc PCVX
Stock Option (Right to Buy) · derivative
|
2021-10-27 | Grant | 30,000 | $0.00 | |
|
OMNI Bio Pharmaceutical Inc OMBP
Warrants (Right to Buy) · derivative
|
2013-01-31 | Grant | 250,000 | $0.00 |